Eren G - Search Results

1

Identification of novel benzimidazole derivatives as inhibitors of leukotriene biosynthesis by virtual screening targeting 5-lipoxygenase-activating protein (FLAP).

Banoglu E, Çalişkan B, Luderer S, Eren G, Özkan Y, Altenhofen W, Weinigel C, Barz D, Gerstmeier J, Pergola C, Werz O. Banoglu E, et al. Among authors: eren g. Bioorg Med Chem. 2012 Jun 15;20(12):3728-41. doi: 10.1016/j.bmc.2012.04.048. Epub 2012 May 1. Bioorg Med Chem. 2012. PMID: 22607880

2

Synthesis, cytotoxic activity on MCF-7 cell line and mutagenic activity of platinum(II) complexes with 2-substituted benzimidazole ligands.

Gümüş F, Algül O, Eren G, Eroğlu H, Diril N, Gür S, Ozkul A. Gümüş F, et al. Among authors: eren g. Eur J Med Chem. 2003 May;38(5):473-80. doi: 10.1016/s0223-5234(03)00058-8. Eur J Med Chem. 2003. PMID: 12767597

3

Synthesis, characterization and preliminary screening of regioisomeric 1-(3-pyridazinyl)-3-arylpyrazole and 1-(3-pyridazinyl)-5-arylpyrazole derivatives towards cyclooxygenase inhibition.

Unlü S, Banoglu E, Ito S, Niiya T, Eren G, Okçelik B, Sahin MF. Unlü S, et al. Among authors: eren g. J Enzyme Inhib Med Chem. 2007 Jun;22(3):351-61. doi: 10.1080/14756360601073468. J Enzyme Inhib Med Chem. 2007. PMID: 17674817 Free article.

4

Synthesis, cytotoxicity, and DNA interactions of new cisplatin analogues containing substituted benzimidazole ligands.

Gümüş F, Eren G, Açik L, Celebi A, Oztürk F, Yilmaz S, Sagkan RI, Gür S, Ozkul A, Elmali A, Elerman Y. Gümüş F, et al. Among authors: eren g. J Med Chem. 2009 Mar 12;52(5):1345-57. doi: 10.1021/jm8000983. J Med Chem. 2009. PMID: 19220055

5

Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors.

Eren G, Unlü S, Nuñez MT, Labeaga L, Ledo F, Entrena A, Banoğlu E, Costantino G, Sahin MF. Eren G, et al. Bioorg Med Chem. 2010 Sep 1;18(17):6367-76. doi: 10.1016/j.bmc.2010.07.009. Epub 2010 Aug 5. Bioorg Med Chem. 2010. PMID: 20692174

6

From Molecular Docking to 3D-Quantitative Structure-Activity Relationships (3D-QSAR): Insights into the Binding Mode of 5-Lipoxygenase Inhibitors.

Eren G, Macchiarulo A, Banoglu E. Eren G, et al. Mol Inform. 2012 Feb;31(2):123-34. doi: 10.1002/minf.201100101. Epub 2012 Jan 20. Mol Inform. 2012. PMID: 27476957

7

Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors.

Eren G, Bruno A, Guntekin-Ergun S, Cetin-Atalay R, Ozgencil F, Ozkan Y, Gozelle M, Kaya SG, Costantino G. Eren G, et al. J Mol Graph Model. 2019 Jun;89:60-73. doi: 10.1016/j.jmgm.2019.02.014. Epub 2019 Mar 5. J Mol Graph Model. 2019. PMID: 30870650

8

Novel pyridazinone derivatives as butyrylcholinesterase inhibitors.

Dundar Y, Kuyrukcu O, Eren G, Senol Deniz FS, Onkol T, Orhan IE. Dundar Y, et al. Among authors: eren g. Bioorg Chem. 2019 Nov;92:103304. doi: 10.1016/j.bioorg.2019.103304. Epub 2019 Sep 18. Bioorg Chem. 2019. PMID: 31561108

9

Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening.

Ozgencil F, Eren G, Ozkan Y, Guntekin-Ergun S, Cetin-Atalay R. Ozgencil F, et al. Among authors: eren g. Bioorg Med Chem. 2020 Jan 1;28(1):115217. doi: 10.1016/j.bmc.2019.115217. Epub 2019 Nov 29. Bioorg Med Chem. 2020. PMID: 31818629

10

Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.

Yagci S, Gozelle M, Kaya SG, Ozkan Y, Aksel AB, Bakar-Ates F, Dundar Y, Eren G. Yagci S, et al. Among authors: eren g. Bioorg Med Chem. 2021 Jan 15;30:115961. doi: 10.1016/j.bmc.2020.115961. Epub 2020 Dec 25. Bioorg Med Chem. 2021. PMID: 33360574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters